|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1965-06-25 |
靶点- |
|
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)
The purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating heart failure patients
Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)
The purposes of the study is to determine the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating Myelodysplastic Syndrome patients.
The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)
The purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.
100 项与 圣释(北京)生物工程有限公司 相关的临床结果
0 项与 圣释(北京)生物工程有限公司 相关的专利(医药)
100 项与 圣释(北京)生物工程有限公司 相关的药物交易
100 项与 圣释(北京)生物工程有限公司 相关的转化医学